Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PULMORA: Tofacitinib vs Methotrexate in Early RA-ILD
NCT04311567Phase 4Terminated
- Sponsor
- Region Västra Götaland
- Start
- Nov 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib in rheumatoid arthritis (RA), interstitial lung disease (ILD), sponsored by Region Västra Götaland. Started Nov 2020; status: terminated.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT04311567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311567.